Yellow fever vaccine - Serum Institute of India
Alternative Names: SII Yellow Fever Vaccine - Serum Institute of India; SII-YFVLatest Information Update: 28 Oct 2024
At a glance
- Originator Serum Institute of India
- Class Attenuated vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Yellow fever
Most Recent Events
- 28 Oct 2024 No recent reports of development identified for preclinical development in Yellow-fever(Prevention) in India (IM)
- 28 Oct 2024 No recent reports of development identified for preclinical development in Yellow-fever(Prevention) in India (SC)
- 10 May 2024 Serum Institute of India completes a phase-III trial in Yellow fever (In adolescents, In adults, In children, In the elderly, Prevention) in Kenya (NCT05421611)